F3 Platform Biologics

F3 is a team of experts in cytoprotection and radioprotection, specializing in solving problems related to low-dose radiation exposure. Our expertise lies in minimizing stochastic effects of radiation – effects that have a higher probability of occurrence with increasing doses or exposures, such as genetic mutations and cancers.

Radiation protection, revolutionized

F3 holds a worldwide exclusive license from the University of Chicago, along with several patents, to develop applications of amifostine in specific markets. Our goal is to bring this science to market in ways that prevent illness, save lives and improve quality of life globally.

F3: Biotech Success Experts

F3 has a track record of success in biotechnology R&D, led by experts in delivering profitable business outcomes that provide significant value for individuals, investors, and partners.